By Will Feuer

Medtronic raised its full-year outlook for sales and adjusted earnings after the medical-device maker reported fiscal second quarter results that topped Wall Street analysts' expectations.

The company is now targeting fiscal-year organic revenue growth of 4.75%, up from 4.5%. Including the anticipated impact from currency fluctuations and other revenue, Medtronic said it anticipated organic growth of 2.6%.

The company also increased its fiscal-year adjusted earnings outlook to $5.13 a share to $5.19 a share, up from a prior range of $5.08 a share to $5.16 a share.

Chief Financial Officer Karen Parkhill cited the company's second-quarter performance and updated estimates for the impact of taxes and foreign currency on fiscal-year results in raising guidance.

Write to Will Feuer at Will.Feuer@wsj.com

(END) Dow Jones Newswires

November 21, 2023 07:27 ET (12:27 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.
Grafico Azioni Medtronic (NYSE:MDT)
Storico
Da Apr 2024 a Mag 2024 Clicca qui per i Grafici di Medtronic
Grafico Azioni Medtronic (NYSE:MDT)
Storico
Da Mag 2023 a Mag 2024 Clicca qui per i Grafici di Medtronic